companydata.dkcompanydata.dk

ACESION PHARMA ApS: Financial statements 2017

CVR: 34083738

Source: annual report 2017, Danish Business Authority

01/01/201731/12/2017

ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -17,450,508 and a net result of DKK -23,972,490 compared with DKK -18,262,257 the year before. Equity in the 2017 report amounted to DKK -9,918,160. The company had 12 employees in the financial year.

Gross Profit
DKK -17,450,508
Profit/Loss
DKK -23,972,490
Equity
DKK -9,918,160
Total Assets
DKK 22,816,866
Employees
12

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017--17.5 mio.-24 mio.-9.9 mio.12
2016--14.4 mio.-18.3 mio.14.1 mio.-
2015--8.5 mio.-9.8 mio.1.5 mio.-
2014--4.7 mio.-6.5 mio.3.8 mio.-
2013--4.8 mio.-6.5 mio.-556 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ACESION PHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

Georgios Trichas joins the board of ACESION PHARMA ApSOct 25, 2017

As of October 25, 2017, Georgios Trichas has joined the board of directors of ACESION PHARMA ApS.

Lars Gredsted leaves the board of ACESION PHARMA ApSOct 25, 2017

As of October 25, 2017, Lars Gredsted has left the board of directors of ACESION PHARMA ApS.

ACESION PHARMA ApS: The 2016 annual report is outMay 29, 2017

ACESION PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -14,393,708, and the net result was DKK -18,262,257.

Jakob Dynnes Hansen joins ACESION PHARMA ApS as directorMar 17, 2017

As of March 17, 2017, Jakob Dynnes Hansen is registered as director of ACESION PHARMA ApS.

Lars Gredsted joins the board of ACESION PHARMA ApSJan 13, 2017

As of January 13, 2017, Lars Gredsted has joined the board of directors of ACESION PHARMA ApS.

About ACESION PHARMA ApS

ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The board consists of Jørgen Søberg Petersen (chair), Benjamin Bruno Thorner, Nik Economopoulos and Timothy Michael Shannon. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees (2018). In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity in the 2025 report amounted to DKK 276,067,000.

Source: annual report 2025, Danish Business Authority